Levels of free fatty acids (FFA) are associated with insulin resistance but do not explain the relationship between adiposity and insulin resistance in Hispanic Americans: the IRAS Family Study
- PMID: 22761463
- PMCID: PMC3431582
- DOI: 10.1210/jc.2012-1318
Levels of free fatty acids (FFA) are associated with insulin resistance but do not explain the relationship between adiposity and insulin resistance in Hispanic Americans: the IRAS Family Study
Abstract
Context and objective: We investigated whether free fatty acids (FFA) mediate the association between adiposity and insulin resistance in the Hispanic-American families of the Insulin Resistance Atherosclerosis Family Study.
Design: In 815 Hispanic individuals in the Insulin Resistance Atherosclerosis Family Study, we tested for association between the following: 1) levels of adiposity [body mass index (BMI), visceral and sc adipose tissue area (VAT and SAT)] and circulating levels of FFA; 2) levels of circulating FFA and insulin sensitivity (S(I)); and 3) levels of adiposity and S(I), additionally testing to see whether levels of FFA mediated or modified the relationship between adiposity and S(I.)
Results: After adjusting for age, sex, clinic site, and admixture, increasing levels of BMI, VAT, and SAT were weakly associated with increasing levels of circulating FFA (BMI: P = 0.024; VAT: P = 2.33 × 10(-3); SAT: P = 0.018; percent variation explained: ∼1.00%). Increasing levels of circulating FFA were associated with decreasing S(I) (P = 8.10 × 10(-11)). Increasing BMI, VAT, and SAT were also associated with decreasing S(I) (BMI: P = 4.98 × 10(-71); VAT: P = 1.48 × 10(-64); SAT: P = 4.21 × 10(-62)), but this relationship was not significantly mediated by FFA. VAT, but not BMI or SAT, interacts with levels of FFA to influence S(I) (P = 0.021).
Conclusions: Although levels of circulating FFA are associated both with increasing adiposity and decreasing S(I), they do not appear to mediate the association between levels of adiposity and S(I) in this large cohort of Hispanic-Americans. These results may indicate that FFA contribute to insulin resistance independent of adiposity.
Figures
References
-
- Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. 1993. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988–1992 - PubMed
-
- Haffner SM, Miettinen H, Gaskill SP, Stern MP. 1995. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386–1391 - PubMed
-
- Weyer C, Bogardus C, Pratley RE. 1999. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48:2197–2203 - PubMed
-
- Boden G. 1997. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL061210/HL/NHLBI NIH HHS/United States
- HL-61210-02/HL/NHLBI NIH HHS/United States
- HL-60894/HL/NHLBI NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- R01 DK029867/DK/NIDDK NIH HHS/United States
- HL-60931-02/HL/NHLBI NIH HHS/United States
- K23 RR022238/RR/NCRR NIH HHS/United States
- R01 HL060944/HL/NHLBI NIH HHS/United States
- HL-60944-02/HL/NHLBI NIH HHS/United States
- R01 HL061019/HL/NHLBI NIH HHS/United States
- R37 DK027619/DK/NIDDK NIH HHS/United States
- HL-61019-02/HL/NHLBI NIH HHS/United States
- R01 HL060894/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials
